Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction

E-ISSN： 1996-3181|13|10|1836-1845

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.13, Iss.10, 2014-12, pp. : 1836-1845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Current Neuropharmacology, Vol. 13, Iss. 5, 2015-09 ,pp. : 663-680

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Cognitive Dysfunction in Major Depressive Disorder - Pathophysiology, Clinical Implications and Treatment Opportunities)

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1637-1639

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Treatment for Cognitive Dysfunction

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 423-431

Bentham Science Publishers

Access to resources Recommend Favorite

Ginseng: potential for the enhancement of cognitive performance and mood

By Kennedy D.O. Scholey A.B.

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 3, 2003-06 ,pp. : 687-700

Elsevier

Access to resources Recommend Favorite

Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?

By McIntyre Roger S Soczynska Joanna K Woldeyohannes Hanna O Lewis Gary F Leiter Lawrence A MacQueen Glenda M Miranda Andrew Fulgosi Don Konarski Jakub Z Kennedy Sidney H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 11, 2007-08 ,pp. : 1615-1628

Informa Healthcare

Access to resources Recommend Favorite